citatuzumab
- Product Name
- citatuzumab
- CAS No.
- 896731-82-1
- Chemical Name
- citatuzumab
- Synonyms
- Conatumumab;citatuzumab;TRAIL-R2 mAb|||AMG 655;Research Grade Conatumumab;Research Grade Citatuzumab;Research Grade Conatumumab(DHA29103)
- CBNumber
- CB01518498
- Formula Weight
- 0
- MOL File
- Mol file
citatuzumab Property
- form
- Liquid
- color
- Colorless to light yellow
N-Bromosuccinimide Price
- Product number
- API0006504
- Product name
- CONATUMUMAB
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $499.07
- Updated
- 2021/12/16
citatuzumab Chemical Properties,Usage,Production
Uses
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers. [1][2][3].
in vivo
Conatumumab (0-100 μg, i.p., twice weekly) inhibits tumor growth in mice bearing Colo205, H2122, or MiaPaCa2/T2 xenograft tumors[2].
Conatumumab (2.5 μg, i.p., three times per week) enhances the antitumor activity of chemotherapeutics (CPT11, HY-16562) (80 mg/kg) in Colo 205 xenograft[2].
| Animal Model: | Mice bearing Colo205, H2122, or MiaPaCa2/T2 xenograft tumors[2] |
| Dosage: | 0, 0.1, 0.3, 1, 3, 10, 30, 100 μg |
| Administration: | Intraperitoneal injection (i.p.), twice weekly. |
| Result: | Dose-dependently inhibited tumor growth. Induced caspase-3 activation in tumors (determined by IHC). |
References
[1] Herbst RS, et al. A first-in-human study of conatumumab in adult patients with advanced solid tumors. Clin Cancer Res. 2010 Dec 1;16(23):5883-91. DOI:10.1158/1078-0432.CCR-10-0631
[2] Kaplan-Lefko PJ, et al. Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types. Cancer Biol Ther. 2010 Apr 15;9(8):618-31. DOI:10.4161/cbt.9.8.11264
citatuzumab Preparation Products And Raw materials
Raw materials
Preparation Products
citatuzumab Suppliers
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- --
- Fax
- --
- sales@acccorporation.com
- Country
- United States
- ProdList
- 6820
- Advantage
- 51
- Tel
- --
- Fax
- --
- wonda@wondascience.com
- Country
- United States
- ProdList
- 2192
- Advantage
- 50